Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-AS02V versus HBVAXPRO in hepatitis B vaccine non-responders with chronic kidney disease requiring dialysis or pre-dialysis care
2005-004058-28Phase 3Completed
- Sponsor
- Henogen
- Start
- Nov 2005
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hepatitis B (HBV) comparing HB-AS02V with HBVAXPRO (2 arms). Primary endpoint: Observed variable. Started Nov 2005; status: completed.
02
Drugs
adjuvanted hepatitis B vaccine HB-AS02VRecombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-004058-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004058-28.